Management Team

Stefan Aigner, M.D., CFA
Chairman, Chief Executive Officer
- More than 30 years of broad healthcare industry experience
- Co-founder and CEO of Inspirion Delivery Technologies and Inspirion Delivery Sciences. Garnered approval of two abuse-deterrent products and raised funding that exceeded $50 MM while negotiating a significant non-dilutive partnership with Daiichi Sankyo.
- Former EVP of corporate development at Alpharma (acquired by King Pharmaceuticals in 2008 for $1.6 billion).
- Co-Founder and EVP of business development and scientific affairs at Reliant Pharmaceuticals. Built a fully integrated pharmaceutical company with 1,400 employees (acquired by GlaxoSmithKline in 2007 for $1.7 billion).
- Healthcare management consultant for the Wilkerson Group
- Board of publicly traded Cipher Pharmaceuticals.

Stefan Aigner, M.D., CFA
Chairman, Chief Executive Officer
- More than 30 years of broad healthcare industry experience
- Co-founder and CEO of Inspirion Delivery Technologies and Inspirion Delivery Sciences. Garnered approval of two abuse-deterrent products and raised funding that exceeded $50 MM while negotiating a significant non-dilutive partnership with Daiichi Sankyo.
- Former EVP of corporate development at Alpharma (acquired by King Pharmaceuticals in 2008 for $1.6 billion).
- Co-Founder and EVP of business development and scientific affairs at Reliant Pharmaceuticals. Built a fully integrated pharmaceutical company with 1,400 employees (acquired by GlaxoSmithKline in 2007 for $1.7 billion).
- Healthcare management consultant for the Wilkerson Group
- Board of publicly traded Cipher Pharmaceuticals.

Hafid Touam
Chief Business Officer

Hafid Touam
Chief Business Officer

Paul Howe
Chief Operating Officer
- More than 2 decades of healthcare industry experience leading commercial teams at both public and private life science companies
- Most recently Senior Vice President Sales and Commercial Strategy at AcelRx, a specialty pharmaceutical company
- Prior to joining AcelRx, held senior roles at Glaxo Smith Kline, XenoPort and Reliant Pharmaceuticals
- Began career at Sanofi (Aventis and Hoechst Marion Roussel)
- Board of Maximus Health

Paul Howe
Chief Operating Officer
- More than 2 decades of healthcare industry experience leading commercial teams at both public and private life science companies
- Most recently Senior Vice President Sales and Commercial Strategy at AcelRx, a specialty pharmaceutical company
- Prior to joining AcelRx, held senior roles at Glaxo Smith Kline, XenoPort and Reliant Pharmaceuticals
- Began career at Sanofi (Aventis and Hoechst Marion Roussel)
- Board of Maximus Health

Eric Kinzler, PhD
VP Medical & Regulatory Affairs; VP Quality Assurance [Acting]

Eric Kinzler, PhD
VP Medical & Regulatory Affairs; VP Quality Assurance [Acting]

Keith James
Chief Financial Officer

Keith James
Chief Financial Officer

Ken Riddle
National Market Access Director
- Twenty-three years experience with market access, covering national & regional accounts, hospital-GPOs, DOD-VA-VISNs system, national health plans, IDNs, PBMs, state FFS-Medicaid, and national managed Medicaid.
- Key experience with CNS market classes: atypical antipsychotics, anti-anxiety, CNS-obesity management, opioid use disorder, and sleep-disorders.
- Leadership positions: Director of Contract Operations-AstraZeneca, Director of Managed Markets-TRIVIDIA Health, National Account Executive-Braeburn Rx, and Director of National Accounts-SCYNEXIS, Inc.

Sharon Salwan
Senior Director, Operations Generalist
